SAF Certifies Adobe Solutions

Adobe digital signature solutions certified by SAFE-BioPharma Association

Dark Reading Staff, Dark Reading

February 6, 2007

1 Min Read

SAN JOSE, Calif. -- Adobe Systems Incorporated (Nasdaq:ADBE) today announced that SAFE(Signatures and Authentication for Everyone)-BioPharma Association has certified AdobeR AcrobatR software, Adobe ReaderR with Adobe LiveCycleR Reader Extensions and Adobe LiveCycle Document Security software for compliance the with the SAFE(TM) digital signature standard. These are the first software products ever certified by SAFE, a non-profit association that manages digital identity and signature standards for pharmaceutical industries.

With today's announcement, legally binding digital signatures are more readily available to biopharmaceutical professionals who need help eliminating the inefficiencies and inaccuracies of paper-based processes while improving end-to-end electronic document workflows. By using the Adobe products certified by SAFE, biopharmaceutical organizations, clinical investigators and regulators can collaborate more securely and efficiently to better service patients, conduct pharmaceutical research, and help bring new drugs to market more quickly.

"The successful certification by SAFE of these Adobe products is very important to ensure that SAFE compliance is guaranteed for product users," said Kay Bross, Senior PKI Specialist, Information Security and Solutions, Procter & Gamble Co. "As Procter & Gamble moves forward to implement SAFE signatures within the enterprise, the utilization of SAFE-compliant tools will offer a stable delivery mechanism on which to build a platform of electronic business transactions."

Adobe Systems Inc.

About the Author(s)

Dark Reading Staff

Dark Reading

Dark Reading is a leading cybersecurity media site.

Keep up with the latest cybersecurity threats, newly discovered vulnerabilities, data breach information, and emerging trends. Delivered daily or weekly right to your email inbox.

You May Also Like

More Insights